Mycobacterium tuberculosis infections cause 2 million deaths every year and latently persist in over 1 billion individuals worldwide (33). Isoniazid (isonicotinic acid hydrazide [INH]) is a frontline antituberculosis agent that is prescribed daily in millions of doses worldwide. While its mechanism(s) of action and cellular targets continue to be uncovered (16, 20) , its full range of effects on mycobacterial cells still remains to be resolved (14, 27). The tubercle bacillus is exceptionally sensitive to INH (7, 36), a prodrug, which is peroxidatively activated by the M. tuberculosis catalase-peroxidase KatG to produce damaging species within the bacteria.
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In keeping with the critical role of INH activation via KatG, the main site for mutations associated with resistance to INH is the katG gene (37) . Several INH-derived intermediates generated during INH activation, such as isonicotinic acyl NADH (20) and mycobacterial targets including enzymes from the mycobacterial type II fatty acid synthase system (1, 16) , have been identified. Other hypotheses regarding INH activation have focused upon INH-derived free radicals as important antimycobacterial intermediates (12, 24, 31) . Despite this progress, the exact mechanism(s) of INH action that underlies its exceptional and specific potency against M. tuberculosis remains to be fully delineated, as multiple targets and pathways have been considered (7, 14, 17, 26) .
NO˙and other reactive nitrogen species have previously been demonstrated to have appreciable activity against M. tuberculosis (5, 15, 35) . The immune response-derived NO˙is considered to contribute to defenses against mycobacterial infection (22) . In this study, we were prompted by reports indicating tyrosine nitration during oxidation of INH (29) , NOḟ ormation from hydroxyurea in vivo (11) , and NO˙formation during horseradish peroxidase-catalyzed oxidation of hydroxyurea in vitro (10) to examine whether NO˙is generated during INH activation by KatG. Based on partial molecular similarities between INH and hydroxyurea, we hypothesized that pathways might exist for NO˙production from INH during its oxidation catalyzed by KatG.
Here we describe the previously unappreciated generation of nitric oxide during activation of INH from its prodrug form into reactive intermediates by the M. tuberculosis catalaseperoxidase KatG. We also present in vivo analysis indicating that NO˙production during INH activation may potentially contribute to the antimycobacterial action of INH.
MATERIALS AND METHODS
In vitro spin trapping of INH-derived NO. A sensitive and NO˙-specific electron paramagnetic resonance (EPR) spin trapping technique was used (13 (28), and purity was confirmed by thin-layer chromatography and 15 N nuclear magnetic resonance. N-methyl-D-glucamine dithiocarbamate was synthesized by the method of Shinobu et al. (23) . EPR spectrometry of these incubations was performed by using a Bruker Elexsys series spectrometer operating at X-band frequencies, at 25°C with samples held in 20-l capillaries. Recombinant KatG was expressed in Escherichia coli and purified by chromatography on DEAE Sepharose CL-6B, Sephacryl S300-HR, and MonoQ HR5/5 columns as previously described (32) .
Treatment of bacterial cultures with INH and NO˙scavenger. Exponentially growing cultures in aerobic roller bottles containing M. tuberculosis var. bovis BCG were exposed to 2 mM 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO; a specific NO˙scavenger) (Alexis Inc., Carlsbad, Calif.) and/or 3.7 M INH for 7 days at 37°C. CPTIO alone had a minor effect, reducing viability by from 100% Ϯ 6.3% to 68% Ϯ 15.5% (number of cultures, 3; P Ͻ 0.05). CPTIO showed no interactions with INH as tested by EPR: the reaction of INH with the nitroxide functional group of CPTIO would cause a loss of EPR signal, and a reaction with the nitrone functional group of CPTIO would cause an alteration in the hyperfine coupling pattern. Bacterial cultures were serially diluted and plated on 7H11 plates for CFU determination.
Nitrotyrosine levels upon exposure to INH. Exponentially growing cultures of M. tuberculosis var. bovis BCG were treated overnight with 73 M INH with or without 1 mM plumbagin (Sigma, St. Louis, Mo.) at 37°C. Cell extracts were obtained by bead beating with 0.1-mm zirconia beads (two 30-s cycles) in a Mini-Beadbeater (Biospec Products Inc., Bartsville, Okla.). Cell extracts were assayed for protein by the Pierce BCA kit (Pierce, Rockford, Ill.) and for nitrotyrosine by using the Hycult Biotechnology Hbt nitrotyrosine enzyme-linked immunosorbent assay (ELISA) kit (Uden, The Netherlands).
RESULTS AND DISCUSSION
NO˙production from KatG activation of INH. We tested whether NO˙was produced during INH activation in an in vitro system consisting of purified components. One advantage of using purified and defined components is the elimination of complications associated with complex mixtures that may contain NADH and other chemical species known to complex with INH in the presence of NAD-binding proteins (20) . NO˙pro-duction was detected during KatG-mediated oxidation of INH in a reaction mixture comprised of purified and previously characterized M. tuberculosis H37Rv KatG (31), INH, and H 2 O 2 (32) (Fig. 1a, spectrum i) . This mixture, consisting of purified components, was identical to the previously published INH activation system (31) , with the single modification of substituting the previously used catalase-insensitive t-butyl hydroperoxide (31) 14 NO˙triplet spectrum (Fig. 1a) to a 15 NOḋ oublet EPR spectrum (Fig. 1a, spectrum ii) , with hyperfine coupling of 1.78 mT, resulting from the different nuclear spins and gyromagnetic ratios of 14 N and 15 N. The generation of NO˙in this in vitro system was consistently reproducible and showed absolute requirements for all components of the system: enzyme (KatG), substrate (INH), and oxidant (H 2 O 2 ) (Fig. 1b) . No signals were observed in the absence of the spin trap Fe(N-methyl-D-glucamine dithiocarbamate) 2 .
Biological activity of NO˙generated during INH-derived NO˙activation. We next tested whether exposure of M. tuberculosis to NO˙generated during the KatG oxidation of INH is potentially toxic to the bacteria. As a control, cultures of M. tuberculosis var. bovis BCG were treated with an NO˙donor, 2,2-(hydroxynitrosohydrazono)-bis-ethanamine (DETA NONOate). Treatment with 1 mM DETA NONOate resulted in a 70% decrease in bacterial survival (Fig. 2a) , in accord with the known potent action of NO˙against M. tuberculosis (5, 15, 35) . Next, M. tuberculosis was treated with INH in the presence or absence of the NO˙scavenger CPTIO. CPTIO was chosen as it is a widely used and specific scavenger of NO˙ (19) . Although hemoprotein NO˙scavengers such as myoglobin and hemoglobin are effective, they were not used to avoid complications due to the addition of iron to the medium and also because they are capable of oxidatively activating INH themselves to form radicals (25) . The addition of CPTIO to INHtreated cultures inhibited the killing of aerobically growing M. tuberculosis var. bovis BCG (Fig. 2b) . CPTIO increased bacterial survival, relative to INH treatment in the absence of CPTIO, by 30-fold from 0.53 to 17.5% (Fig. 2b) . A direct reaction between INH and CPTIO was excluded (assayed by EPR of the nitroxide CPTIO), confirming that the action of CPTIO was mediated by the scavenging of INH-derived NOȧ nd not by a fortuitous sequestering or reaction with INH.
Analysis of biological indications for peroxynitrite formation. NO˙is often thought to exert antimicrobial activity through its reaction with superoxide (O 2 ⅐Ϫ ) to form peroxynitrite, a reactive species capable of oxidizing and nitrating (Fig. 2c) showed no increase above background levels. There was no increase in nitrotyrosine even in the presence of plumbagin, a known redox-cycling agent stimulating O 2 ⅐Ϫ production (4), which is known to potentiate INH action (3) and is thus expected to increase peroxynitrite formation (which is formed by reaction of O 2 ⅐Ϫ and NO˙). Western blot analysis (data not shown) also showed no increases in nitrotyrosine levels above the background in M. tuberculosis var. bovis BCG protein extracts upon INH treatment.
Conclusions.
The studies presented here with 15 N-labeled INH unequivocally demonstrate that NO˙is generated from the INH hydrazide group during activation by M. tuberculosis KatG. A potential pathway of NO˙formation is shown in Fig.  3 , based upon the known importance of the hydrogen at the hydrazide N 2 (i.e., a lack of substitution by alkyl or other groups) (8) and the requirement for oxygen for maximal INH activity (34) . However, the reaction pathway after the N-O bond formation from the reaction of the nitrogen-centered radical with oxygen (9) is as yet unclear. Our bacterial survival assays suggest that the NO˙generated in vivo during oxidation of INH may have appreciable activity. Although the NO˙scav-enger CPTIO caused substantial protection of mycobacteria against INH action, it is evident from the experimental data that it did not fully protect M. tuberculosis var. bovis BCG (18, 25) to form the hydrazyl radical (2) is followed by oxygen addition to the hydrazyl radical (causing N-O bond formation) (3), followed by as yet undelineated fragmentation or elimination. (20) . Alternatively, the incomplete protection by CPTIO can be explained as resulting from any of the following: (i) incomplete scavenging of NO˙, (ii) antimycobacterial activity of one of the products of NO˙scavenging by CPTIO, (iii) the activity of additional INH-derived radical species (31), and/or (iv) the slight effects of CPTIO on growth itself. It should be acknowledged that it is unlikely that NO˙is the only product of INH contributing to its overall antituberculosis action, as other studies have shown that INH-NAD adducts are another class of major toxic products responsible for the antimycobacterial action of INH (1, 20) . Nevertheless, the unambiguous generation of NO˙from INH and its detectable effects on mycobacteria suggest the possibility of enhancing this property of INH as a potential strategy for generating new antituberculosis drugs. Such ideas already have preliminary validation, as it has recently been shown that the addition of NO˙-releasing groups to ciprofloxacin greatly increases its activity against M. tuberculosis (6).
